Elisabeth L. Schwarz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Elisabeth L. Schwarz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Marzia Pasquali
ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City
2 shared publicationsAiping Liu
ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories, Salt Lake City
1 shared publicationChrista Haslip
ARUP Laboratories Inc., Salt Lake City
1 shared publicationFay Keune
Utah Department of Health, Newborn Screening Follow-up Program, Salt Lake City
1 shared publicationHarper Randall
Utah Department of Health, Newborn Screening Follow-up Program, Salt Lake City
1 shared publicationMary Murray
Departments of Pediatrics, University of Utah, Salt Lake City
1 shared publication
Latest Publications
- Open Access
- 1 August 2009
- Published by Springer Nature in Pediatric Research
- Vol. 66 (2) , 230-235
Use of Steroid Profiling by UPLC-MS/MS as a Second Tier Test in Newborn Screening for Congenital Adrenal Hyperplasia: The Utah Experience
Newborn screening allows the diagnosis of congenital adrenal hyperplasia (CAH) before symptoms appear, preventing the severe and potentially life-threatening crisis associated with this disease in infancy. Traditional screening by enzyme immunoassay results in a large number of false positives. To reduce the number of unnecessary tests, anxiety to families and physicians, and the burden to the newborn screening follow-up program, we implemented a second-tier test for CAH using steroid profiling by an ultra-performance liquid chromatography-tandem mass spectrometry. We measured three steroids: 17-hydroxyprogesterone, androstenedione, and cortisol and correlated them with the age of infant at the time of sample collection and birth weight. Both age at collection and birth weight affected the levels of adrenal steroids, but the use of appropriate cut offs and analyte ratios allowed the identification of infants with CAH. This approach was effective in identifying infants with CAH, with both salt-wasting and simple virilizing forms, while reducing the false-positive rate from 2.6 to 0.09%.
- 1 August 2009
- Published by Springer Nature in Pediatric Research
- Vol. 66 (2) , 230-235
Open AccessUse of Steroid Profiling by UPLC-MS/MS as a Second Tier Test in Newborn Screening for Congenital Adrenal Hyperplasia: The Utah Experience
Newborn screening allows the diagnosis of congenital adrenal hyperplasia (CAH) before symptoms appear, preventing the severe and potentially life-threatening crisis associated with this disease in infancy. Traditional screening by enzyme immunoassay results in a large number of false positives. To reduce the number of unnecessary tests, anxiety to families and physicians, and the burden to the newborn screening follow-up program, we implemented a second-tier test for CAH using steroid profiling by an ultra-performance liquid chromatography-tandem mass spectrometry. We measured three steroids: 17-hydroxyprogesterone, androstenedione, and cortisol and correlated them with the age of infant at the time of sample collection and birth weight. Both age at collection and birth weight affected the levels of adrenal steroids, but the use of appropriate cut offs and analyte ratios allowed the identification of infants with CAH. This approach was effective in identifying infants with CAH, with both salt-wasting and simple virilizing forms, while reducing the false-positive rate from 2.6 to 0.09%.
- 1 April 2005
- Published by Elsevier in Clinica Chimica Acta
- Vol. 354 (1-2) , 83-90
Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection
- 1 April 2005
- Published by Elsevier in Clinica Chimica Acta
- Vol. 354 (1-2) , 83-90
Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection